Highly Active Antiretroviral Therapy

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Ginecomastia bilateral en un paciente con infección por virus de la inmunodeficiencia humana de tipo 1

Medical Microbiology / HIV / Humans / Male / Gynecomastia / Human immunodeficiency virus / Adult / Highly Active Antiretroviral Therapy / Anorexia / Enfermedades / Human immunodeficiency virus / Adult / Highly Active Antiretroviral Therapy / Anorexia / Enfermedades

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Resistencias genotípicas en pacientes con VIH-1 y grados de viremia persistentemente bajos

Medical Microbiology / HIV / Antiretroviral Therapy / Humans / HIV protease / Highly Active Antiretroviral Therapy / Enfermedades / Viral Load / Highly Active Antiretroviral Therapy / Enfermedades / Viral Load

Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero de 2007)

Evidence Based Medicine / Medical Microbiology / Comorbidity / Spain / Therapeutic drug monitoring / Pregnancy / Humans / Female / Male / Hiv Infection / Adult / Highly Active Antiretroviral Therapy / Combination drug therapy / Disease Progression / Viral Load / Pregnancy / Humans / Female / Male / Hiv Infection / Adult / Highly Active Antiretroviral Therapy / Combination drug therapy / Disease Progression / Viral Load

Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el VIH (octubre 2004)

Evidence Based Medicine / Medical Microbiology / Comorbidity / Spain / Therapeutic drug monitoring / Pregnancy / Humans / Female / Male / Hiv Infection / Adult / Highly Active Antiretroviral Therapy / Combination drug therapy / Disease Progression / Viral Load / Pregnancy / Humans / Female / Male / Hiv Infection / Adult / Highly Active Antiretroviral Therapy / Combination drug therapy / Disease Progression / Viral Load

Sobreelevación de tatuaje en un paciente infectado por virus de la inmunodeficiencia humana

Medical Microbiology / Humans / Male / Visceral Leishmaniasis / Patient Compliance / Recurrence / Tattooing / Human immunodeficiency virus / Adult / Highly Active Antiretroviral Therapy / Cutaneous Leishmaniasis / Lamivudine / Organometallic Compounds / Pentamidine / Recurrence / Tattooing / Human immunodeficiency virus / Adult / Highly Active Antiretroviral Therapy / Cutaneous Leishmaniasis / Lamivudine / Organometallic Compounds / Pentamidine

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA para el tratamiento antirretroviral inicial

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2012 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana (VIH)

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Análisis de costes y de coste/eficacia de las pautas preferentes de GESIDA/Plan Nacional sobre el Sida en 2013 para el tratamiento antirretroviral inicial en adultos infectados por el virus de la inmunodeficiencia humana

Expert testimony / Clinical Trial / Medical Microbiology / Treatment Outcome / Spain / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic / Decision Trees / Antiretroviral Therapy / Humans / Therapy / Hiv Infection / Cost effectiveness / Efficiency / Health Expenditures / Theoretical Models / Genotype / Adult / Economic Models / Cost Benefit Analysis / Highly Active Antiretroviral Therapy / Drug Costs / Combination drug therapy / Disease Management / Clinical Protocols / Acquired immunodeficiency syndrome / Viral Load / Clinical Trials as Topic

Phase II Trial of Infusional Cyclophosphamide, Idarubicin, and Etoposide in Poor Prognosis Non-Hodgkin’s Lymphoma

Dentistry / Survival Analysis / Treatment Outcome / Humans / Female / Clinical / Male / Clinical oncology / American / Aged / Middle Aged / Doxorubicin / Adult / Highly Active Antiretroviral Therapy / Prognosis / Cyclophosphamide / Phase II Trial / Clinical / Male / Clinical oncology / American / Aged / Middle Aged / Doxorubicin / Adult / Highly Active Antiretroviral Therapy / Prognosis / Cyclophosphamide / Phase II Trial

Genetic Characterization of Human Immunodeficiency Virus Type 1 in Elite Controllers: Lack of Gross Genetic Defects or Common Amino Acid Changes

Genetics / Microbiology / Immunology / Polymorphism / Molecular Evolution / Medical Microbiology / Virology / Mozambique / Adolescent / HIV / Genetic Diversity / Biological Sciences / Phylogeny / Pregnancy / Humans / Child / Sequence alignment / Mutation / Microbes / Female / Blood / Drug Resistance / Blood sampling / Male / Sexual Behavior / Polymerase Chain Reaction / Infant / AIDS / Clinical Sciences / Vagina / Middle Aged / Molecular cloning / Human immunodeficiency virus / Adult / Time Factors / Highly Active Antiretroviral Therapy / Hiv seropositivity / Amino Acid Profile / Semen / Amino Acid Sequence / Base Sequence / Lymphocytes / Reverse Transcriptase / Binding Site / Viral Load / Medical Microbiology / Virology / Mozambique / Adolescent / HIV / Genetic Diversity / Biological Sciences / Phylogeny / Pregnancy / Humans / Child / Sequence alignment / Mutation / Microbes / Female / Blood / Drug Resistance / Blood sampling / Male / Sexual Behavior / Polymerase Chain Reaction / Infant / AIDS / Clinical Sciences / Vagina / Middle Aged / Molecular cloning / Human immunodeficiency virus / Adult / Time Factors / Highly Active Antiretroviral Therapy / Hiv seropositivity / Amino Acid Profile / Semen / Amino Acid Sequence / Base Sequence / Lymphocytes / Reverse Transcriptase / Binding Site / Viral Load

Trasplante hepático en pacientes con infección por el VIH: una realidad en el año 2004

Medical Microbiology / Drug interactions / Hepatitis C / Hepatology / HIV / Spain / Liver diseases / Humans / Liver Cirrhosis / Organ Transplantation / Follow-up studies / Liver Transplantation / Hiv Infection / Waiting lists / Clinical Sciences / Survival Rate / Highly Active Antiretroviral Therapy / Liver Failure / Hepatitis B virus / Graft Rejection / Viral Load / Socioeconomic Factors / Spain / Liver diseases / Humans / Liver Cirrhosis / Organ Transplantation / Follow-up studies / Liver Transplantation / Hiv Infection / Waiting lists / Clinical Sciences / Survival Rate / Highly Active Antiretroviral Therapy / Liver Failure / Hepatitis B virus / Graft Rejection / Viral Load / Socioeconomic Factors

PeRCePCIoNeS De LAS PeRSoNAS VIVIeNDo CoN VIH/SIDA SoBRe LoS SeRVICIoS De SALUD Y eL TRATAMIeNTo ANTIRReTRoVIRAL De GRAN ACTIVIDAD: UN eSTUDIo TRANSVeRSAL eN CINCo CIUDADeS DeL PeRÚ

Peru / Quality of Care / Health Services / Health Care Services / Sample Size / Research Needs / Highly Active Antiretroviral Therapy / People Living With HIV/AIDS / Cross sectional Study / Health Personnel / Research Needs / Highly Active Antiretroviral Therapy / People Living With HIV/AIDS / Cross sectional Study / Health Personnel

Human immunodeficiency virus infection in pregnant women in Nigeria

Microbiology / Medical Microbiology / Pregnancy / Humans / Female / Gynecology and Obstetrics / Obstetrics Gynecology / Data Collection / Clinical Sciences / Newborn Infant / Fetal maternal medicine / Human immunodeficiency virus / Highly Active Antiretroviral Therapy / Pregnant Women / Human Milk / Prenatal Diagnosis / Prenatal Care / Pregnancy Outcome / Acquired immunodeficiency syndrome / Gynecology and Obstetrics / Obstetrics Gynecology / Data Collection / Clinical Sciences / Newborn Infant / Fetal maternal medicine / Human immunodeficiency virus / Highly Active Antiretroviral Therapy / Pregnant Women / Human Milk / Prenatal Diagnosis / Prenatal Care / Pregnancy Outcome / Acquired immunodeficiency syndrome

Phase II Trial of Infusional Cyclophosphamide, Idarubicin, and Etoposide in Poor Prognosis Non-Hodgkin’s Lymphoma

Dentistry / Survival Analysis / Treatment Outcome / Humans / Female / Clinical / Male / Clinical oncology / American / Aged / Middle Aged / Doxorubicin / Adult / Highly Active Antiretroviral Therapy / Prognosis / Cyclophosphamide / Phase II Trial / Clinical / Male / Clinical oncology / American / Aged / Middle Aged / Doxorubicin / Adult / Highly Active Antiretroviral Therapy / Prognosis / Cyclophosphamide / Phase II Trial
Copyright © 2017 DATOSPDF Inc.